204 related articles for article (PubMed ID: 1601530)
1. A distribution-free procedure for the statistical analysis of bioequivalence studies.
Hauschke D; Steinijans VW; Diletti E
Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S37-43. PubMed ID: 1601530
[TBL] [Abstract][Full Text] [Related]
2. A distribution-free procedure for the statistical analysis of bioequivalence studies.
Hauschke D; Steinijans VW; Diletti E
Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):72-8. PubMed ID: 2307548
[TBL] [Abstract][Full Text] [Related]
3. Update on the statistical analysis of bioequivalence studies.
Steinijans VW; Hauschke D
Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S45-50. PubMed ID: 1601531
[TBL] [Abstract][Full Text] [Related]
4. Sample size determination for bioequivalence assessment by means of confidence intervals.
Diletti E; Hauschke D; Steinijans VW
Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S51-8. PubMed ID: 1601532
[TBL] [Abstract][Full Text] [Related]
5. Update on the statistical analysis of bioequivalence studies.
Steinijans VW; Hauschke D
Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):105-10. PubMed ID: 2318545
[TBL] [Abstract][Full Text] [Related]
6. Sample size determination for bioequivalence assessment by means of confidence intervals.
Diletti E; Hauschke D; Steinijans VW
Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):1-8. PubMed ID: 2004861
[TBL] [Abstract][Full Text] [Related]
7. Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43.
Diletti E; Hauschke D; Steinijans VW
Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):287-90. PubMed ID: 1526691
[TBL] [Abstract][Full Text] [Related]
8. [Review and use of decision rules for bioequivalence trials].
Nicolas P; Tod M; Petitjean O
Therapie; 1993; 48(1):15-22. PubMed ID: 8356540
[TBL] [Abstract][Full Text] [Related]
9. Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43.
Diletti E; Hauschke D; Steinijans VW
Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S59-62. PubMed ID: 1601533
[TBL] [Abstract][Full Text] [Related]
10. Choice of student's t- or Wilcoxon-based confidence intervals for assessment of average bioequivalence.
Hauck WW; Hauschke D; Diletti E; Bois FY; Steinijans VW; Anderson S
J Biopharm Stat; 1997 Mar; 7(1):179-89. PubMed ID: 9056597
[TBL] [Abstract][Full Text] [Related]
11. On TIER method for assessment of individual bioequivalence.
Ju HL
J Biopharm Stat; 1997 Mar; 7(1):63-85. PubMed ID: 9056589
[TBL] [Abstract][Full Text] [Related]
12. Types of bioequivalence and related statistical considerations.
Hauck WW; Anderson S
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546
[TBL] [Abstract][Full Text] [Related]
13. Robust and bootstrap testing procedures for bioequivalence.
Shen CF; Iglewicz B
J Biopharm Stat; 1994 Mar; 4(1):65-90. PubMed ID: 8019585
[TBL] [Abstract][Full Text] [Related]
14. [Statistical tests for bioequivalence].
Peil H; Häselbarth V
Arzneimittelforschung; 1985; 35(10):1489-94. PubMed ID: 4074402
[TBL] [Abstract][Full Text] [Related]
15. The impact of outlying subjects on decision of bioequivalence.
Ki FY; Liu JP; Wang W; Chow SC
J Biopharm Stat; 1995 Mar; 5(1):71-94. PubMed ID: 7613561
[TBL] [Abstract][Full Text] [Related]
16. Discussion of individual bioequivalence by M.-L. Chen.
Gould AL
J Biopharm Stat; 1997 Mar; 7(1):23-9. PubMed ID: 9056584
[TBL] [Abstract][Full Text] [Related]
17. A two one-sided tests procedure for assessment of individual bioequivalence.
Liu J; Chow SC
J Biopharm Stat; 1997 Mar; 7(1):49-61. PubMed ID: 9056588
[TBL] [Abstract][Full Text] [Related]
18. Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics.
Brannath W; Bretz F; Maurer W; Sarkar S
Biom J; 2009 Dec; 51(6):885-98. PubMed ID: 20014203
[TBL] [Abstract][Full Text] [Related]
19. Average bioequivalence of two oral formulations of fluconazole in healthy subjects after multiple dosing.
Atanasova I; Bozhinova K; Terziivanov D
Int J Clin Pharmacol Ther; 1999 Jun; 37(6):282-5. PubMed ID: 10395119
[TBL] [Abstract][Full Text] [Related]
20. Analysis of metabolites--a new approach to bioequivalence studies of spironolactone formulations.
Vergin H; Mahr G; Metz R; Eichinger A; Nitsche V; Martens H
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):334-40. PubMed ID: 9266289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
